What's your reaction to the NHS 'breakthrough' breast cancer drug?

We’d like to hear from people affected by this story and find out what this means for the availability of other drugs

Two ‘breakthrough’ breast cancer drugs are to be available on the NHS after the National Institute for Health and Care Excellence (Nice) negotiated prices for the treatments.

The standard price for one cycle of palbociclib is £2,950 for a pack of 21 capsules. The list price for one cycle of ribociclib is also £2,950 but this is for 63 tablets. The company had first offered the drug at a price that was rejected by NICE, but they had later come to a “confidential agreement around the price”.

Related: Thousands to benefit as 'breakthrough' breast cancer drugs approved for NHS use

Continue reading... November 16, 2017 at 10:14PM